BOSTON SCIENTIFIC CORPORATION

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

RHythmia mAPping and Signal acquisitiOn for Data analYsis (RHAPSODY)

Recruiting

Conditions: Cardiac Arrythmias

Interventions: Device: Rhythmia Mapping System

First Posted Date: 2017-02-14

Last Posted Date: 2024-12-20

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 100

Registration Number: NCT03053141

Locations: 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States
🇮🇹
Fondazione Centro San Raffaele, Milan, MI, Italy
🇺🇸
St. Lukes Idaho Cardiology Associates, Boise, Idaho, United States

and more 4 locations

Performance and Safety of the Lotus™ Valve With a FLEXible Delivery System

Not Applicable

Completed

Conditions: Aortic Stenosis

Interventions: Device: Transcatheter aortic valve replacement

First Posted Date: 2017-02-06

Last Posted Date: 2019-07-05

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 4

Registration Number: NCT03043404

Locations: 🇦🇺
Prince Charles Hospital, Chermside, Queensland, Australia
🇦🇺
Monash Heart, Clayton, Victoria, Australia

Closed Loop Programming Evaluation Using External Responses for Deep Brain Stimulation

Not Applicable

Recruiting

Conditions: Parkinson Disease

Interventions: Device: Vercise Deep Brain Stimulation System

First Posted Date: 2017-01-31

Last Posted Date: 2024-12-05

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 100

Registration Number: NCT03037398

Locations: 🇩🇪
University Berlin, Charite Virchow Standort, Wedding, Berlin, Germany
🇩🇪
Universitaetsklinik Eppendorf, Hamburg, Germany
🇩🇪
Universitätsklinikum Campus Kiel, Kiel, Germany

A Real World Evaluation of the ELUVIA Stent in Subjects With Lesions Located in the Femoropopliteal Arteries

Completed

Conditions: Vascular Diseases
Arterial Occlusive Diseases
Atherosclerosis
Arteriosclerosis

Interventions: Device: Peripheral stenting

First Posted Date: 2017-01-31

Last Posted Date: 2022-11-28

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 291

Registration Number: NCT03037411

Locations: 🇫🇷
Clinique Parly II, Le Chesnay, France
🇧🇪
ZOL Genk, Genk, Limburg, Belgium
🇦🇹
Medizinische Universität Graz, Graz, Austria

and more 20 locations

Study to Characterize Effects of Programming in SCS Patients Undergoing a Temporary Trial

Not Applicable

Completed

Conditions: Chronic Pain

Interventions: Device: Programming

First Posted Date: 2016-12-09

Last Posted Date: 2022-04-18

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 35

Registration Number: NCT02988713

Locations: 🇺🇸
PCPMG Clinical Research Unit, LLC, Greenville, South Carolina, United States
🇺🇸
Pacific Pain Management, Inc., Ventura, California, United States

REPRISE EDGE 29 mm EU Study

Not Applicable

Withdrawn

Conditions: Aortic Valve Stenosis

Interventions: Device: 29 mm LOTUS Edge™ Valve System

First Posted Date: 2016-11-16

Last Posted Date: 2019-07-05

Lead Sponsor: Boston Scientific Corporation

Registration Number: NCT02964962

Ranger™ and Ranger™ SL (OTW) DCB) in China

Not Applicable

Completed

Conditions: Femoropopliteal Artery Lesions

Interventions: Device: Boston Scientific Ranger™ and Ranger™ SL Paclitaxel-Coated PTA Balloon Catheter

First Posted Date: 2016-10-25

Last Posted Date: 2024-12-20

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 123

Registration Number: NCT02944071

Locations: 🇨🇳
Beijing Tongren Hospital, Capital Medical University, BeiJing, Beijing, China
🇨🇳
The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China
🇨🇳
Jiangsu Province Hospital, Nanjing, Jiangsu, China

and more 6 locations

Rezum I Pilot Study for Benign Prostatic Hyperplasia

Not Applicable

Completed

Conditions: Prostatic Adenoma
Prostatic Hyperplasia
Prostatic Hypertrophy
Rezum
Benign Prostatic Hyperplasia
Adenoma, Prostatic
Prostatic Hyperplasia, Benign
Prostatic Hypertrophy, Benign

Interventions: Device: Rezum System

First Posted Date: 2016-10-24

Last Posted Date: 2021-03-16

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 50

Registration Number: NCT02943070

Locations: 🇸🇪
Urologcentrum, Stockholm, Sweden
🇨🇿
University Hospital, Brno, Czechia
🇩🇴
Clinica Canela, La Romana, Dominican Republic

Rezum FIM Optimization Study

Not Applicable

Completed

Conditions: Adenoma, Prostatic
Prostatic Adenoma
Rezum
Benign Prostatic Hyperplasia
Prostatic Hypertrophy, Benign
Prostatic Hyperplasia, Benign
Prostatic Hypertrophy

Interventions: Device: Rezum System

First Posted Date: 2016-10-20

Last Posted Date: 2021-03-05

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 15

Registration Number: NCT02940392

Locations: 🇩🇴
Clinica Canela, La Romana, Dominican Republic

Assessment of the WATCHMAN™ Device in Patients Unsuitable for Oral Anticoagulation

Not Applicable

Active, not recruiting

Conditions: Stroke

Interventions: Drug: Single Antiplatelet Therapy or No Therapy (Control)
Device: WATCHMAN LAAC Device Implant

First Posted Date: 2016-10-10

Last Posted Date: 2024-12-18

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 481

Registration Number: NCT02928497

Locations: 🇺🇸
OhioHealth Research and Innovation Institute - Riverside Methodist Hospital, Columbus, Ohio, United States
🇺🇸
Cedars - Sinai Medical Center, Los Angeles, California, United States
🇺🇸
Emory University Hospital, Atlanta, Georgia, United States

and more 89 locations

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy